Introduction {#sec1-1}
============

Severe traumatic brain injury (TBI) is a leading cause of death and disability among men between the ages of 20 to 60 years (Werner et al., 2007). TBI can result in cellular energy failure in common metabolic pathways. In the first 24 hours after injury, ischemia results in decreased O~2~ delivery, leading to inefficient oxidative cerebral metabolism. A cascade of biochemical events lead in turn to mitochondrial dysfunction and a prolonged period of hypometabolism. Furthermore, diffusion barriers to the cellular delivery of O~2~ develop and persist. The degree to which cerebral oxidative metabolism is restored correlates with the clinical outcome (Sarah et al., 2010). Because advancing the rehabilitation of nervous function can minimize the insults, decrease the neurological disability, and optimize the patients' prognosis after TBI, it has become an important topic of study.

Despite several encouraging animal studies, human TBI trials assessing different pharmacological neuroprotective agents have all failed to show any efficacy (Tisdall et al., 2007). Hyperbaric oxygen (HBO) might be a promising intervention for TBI. HBO could elevate the oxygen concentration gradient and could facilitate regeneration of blood vessels within the injured tissue (Rockswold et al., 1992; Gill et al., 2004). Indeed, this is a major intervention for TBI patients in China during their rehabilitation.

HBO leads to a post-treatment effect (Hadanny et al., 2015), in which HBO retention can occur in injured brain tissue after the HBO cure because of poor blood circulation (Bennett et al., 2014). We hypothesized that because brain-tissue oxygen pressure is higher in the injured area, the cerebral regional transcranial oxygen saturation (rSO~2~) would also be elevated. Near-infrared spectroscopy (NIRS) is a developing technology for noninvasive assessment of cerebral oxygenation (Hyttel-Sorensen et al., 2015). In recent years, NIRS has been accepted as a means for clinicians to measure the rSO~2~ of cerebral and somatic tissues in the clinical setting (Drayna et al., 2011). The aim of the current study was to evaluate the differences in bi-hemispheric measurement of cerebral oxygenation using NIRS pre- and post-HBO.

Patients and Methods {#sec1-2}
====================

Patients {#sec2-1}
--------

This prospective, observational study was approved by the Ethics Committee of the Second Affiliated Hospital of Soochow University, China. Informed consent was received from all patients involved in the study, or their relatives, including consent to publish.

Two groups were compared in this study. The control group comprised 20 healthy individuals (hospital staff) and the TBI group comprised 40 TBI patients who were selected from the Department of Neurosurgery, High-tech District Branch of the Second Affiliated Hospital of Soochow University. According to the usual rehabilitation plan, patients who suffered from a sub-acute traumatic brain injury with a possibility to be treated with HBO were enrolled in the study.

### TBI group inclusion criteria {#sec3-1}

\(1\) Age 18--60 years, (2) time after TBI: 4--12 days, (3) no contraindication for HBO, and (4) no hypertension or diabetes mellitus.

### TBI group exclusion criteria {#sec3-2}

\(1\) History of TBI, (2) history of stroke, (3) broken skin on the forehead, or (4) history of severe pulmonary disease (including asthma or chronic obstructive pulmonary disease).

### Healthy group inclusion criteria {#sec3-3}

\(1\) Age: 18--60 years, and (2) no history of stroke.

### Healthy group exclusion criterion {#sec3-4}

Broken skin on the forehead.

Treatment {#sec2-2}
---------

HBO treatment was given to all TBI patients 4--12 days (average 8 days) after injury. The patients sat in a hyperbaric multiplace chamber (Shc2800-8000-10/4, Shanghai 701 Yang Garden Hyperbaric Oxygen Chamber Co., Ltd.) that was compressed to a pressure of 240 kPa within 15 minutes, and then given 100% oxygen with an oronasal mask at a pressure of 240 kPa for three cycles of 30 minutes. In between cycles, they breathed air at a pressure of 240 kPa for 5 minutes. Afterward, they were decompressed to a normal atmospheric pressure over a 15-minute period.

Cerebral oxygen saturation monitor {#sec2-3}
----------------------------------

Cerebral dosimeter sensors were placed on both sides of the forehead with the medial edge of the sensor at the midline. rSO~2~ was measured for 30 minutes with a Somanetics INVOS 5100 monitor (NIRS monitor, Somanetics INVOS system, Somanetics Inc., Minneapolis, Minnesota, USA) before the 90-minute HBO treatment. At the same time, arterial blood was sampled for a blood-gas analysis. Fifteen minutes after the HBO treatment, the same measurements were taken for 30 minutes, and the blood sampling was duplicated. In the healthy individuals, rSO~2~ was measured once over a 30-minute period.

Statistical analysis {#sec2-4}
--------------------

Data analyses were performed with SPSS 13.0 software (SPSS, Chicago, IL, USA). Data are expressed as the mean ± SD. Comparisons within group and between groups were made based on paired *t*-tests and two sample *t*-test, respectively. The threshold for statistical significance was set to *P* \< 0.05.

Results {#sec1-3}
=======

Patient characteristics {#sec2-5}
-----------------------

Forty patients with sub-acute TBI were evaluated during the course of this study. There was no difference in age between the two groups (**[Table 1](#T1){ref-type="table"}**). Furthermore, no significant changes were observed in body temperature, heart rate, frequency of respiration, or blood pressure during the study protocol (**[Table 2](#T2){ref-type="table"}**).

###### 

Baseline data
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###### 

Vital signs of the traumatic brain injury patients
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The rSO~2~ {#sec2-6}
----------

rSO~2~ was significantly less in the patient group compared with controls (*P* \< 0.05), but did not significantly differ among patients before and after HBO treatment (*t* = 0.352, *P* \> 0.05). Compared with the left frontal area, rSO~2~ was not significantly higher in the right (*t* = 0.469, *P* \> 0.05) (**[Table 3](#T3){ref-type="table"}**).

###### 

Comparison of rSO~2~ betwen the two groups

![](NRR-11-1445-g004)

Variables of blood gas analysis {#sec2-7}
-------------------------------

There were no significant differences in the PaCO~2~, pH, or HCO~3~ values between pre- and post-HBO treatment. However, we did observe a significant reduction in PaO~2~ after treatment (*P* \< 0.05) (**[Table 4](#T4){ref-type="table"}**).

###### 

Comparison of variables of blood gas analysis in traumatic brain injury
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Discussion {#sec1-4}
==========

This was a report on an observational clinical trial that used NIRS to examine the effect of HBO therapy in TBI patients. rSO~2~ did not significantly differ among TBI patients before and after HBO treatment. Ischemia and hypoxia are known to be dangerous secondary injuries that can appear 7--14 days after TBI (Vigue et al., 1999). Oxygen delivery to brain tissue could be impaired by the reduced O~2~ diffusion into brain cells (Menon et al., 2004), which can result in low PO~2~ levels. PO~2~ levels in brain tissue is known to be associated with the clinical outcome (van den Brink et al., 2000; Stiefel et al., 2006). Oxygen delivery depends on a pressure gradient from the alveolar spaces to the blood, and finally to the brain tissue itself. Hyperbaric O~2~ could increase the vital O~2~ delivery pressure gradient (Beynon et al., 2012), which could subsequently improve cerebral aerobic metabolism after brain injury (Guedes et al., 2016). Studies have shown that HBO decreases the mortality rates and improves the functional outcome in TBI patients (Boussi-Gross et al., 2013). HBO also improves wound healing by amplifying the oxygen gradients along the periphery of the ischemic compounds and by promoting oxygen-dependent collagen formation needed for angiogenesis. Because oxygen exists in the solution, it can reach into the physically obstructed areas where red blood cells cannot pass, which could enable tissue oxygenation despite impaired hemoglobin oxygen transport, such as in the case of carbon monoxide poisoning or severe anemia. PO~2~ monitoring in brain tissue ranges 200--300 mmHg with HBO at 1.5 ATA.

The principle of NIRS has been well documented (Neshat Vahid et al., 2014). The near-infrared light is absorbed at a wave length of 700--1,300 nm, and passes through a material, which is determined by the molecular properties of the material in the light path (Suffoletto et al., 2012). In the mammalian brain, only hemoglobin and cytochrome c oxidase absorb the near-infrared light, and the extent of this absorption changes with the oxygenation state of these two compounds (Xiao et al., 2004). The rSO~2~ is accordingly a measure of the blood oxygen saturation in the brain\'s gas-exchanging circulation (arterioles, capillaries, and veins). Bi-hemispheric measurement of cerebral oxygen saturation could detect oxygenation metabolism in different brain regions. The comparison of rSO~2~ between the left and right frontal areas has not been previously reported in patients after HBO treatment. NIRS allows a noninvasive assessment of cerebral hemodynamics and oxygenation. The absolute value of the rSO~2~ measurement, which represents all the cerebral blood compartments except the larger vessels, was a relatively focal measurement. Cerebral oxygenation monitoring using NIRS detected the changes in oxygenation earlier than what standard pulse oximetry can provide (Tobias, 2008). Therefore, NIRS could be a promising and sensitive means to assess cerebral oxygen consumption.

Oxidative metabolism could be markedly reduced in large regions of the brain after TBI (Diringer et al., 2002; Coles et al., 2004; Vespa et al., 2005). Here, we report that the rSO~2~ of patients with a sub-acute TBI was lower than that of healthy individuals. We also found that the rSO~2~ of these patients did not significantly change after the HBO treatment. This lack of the cerebral oxygenation elevation after the HBO treatment was not expected. There could be several reasons to explain this phenomenon. The rSO~2~ values could have been affected by the hemoglobin concentration, skull thickness, the differential path length factor, extracranial blood contamination, the area of the cerebrospinal fluid layer, or the sensor location (Kishi et al., 2003; Yoshitani et al., 2007; Leal-Noval et al., 2010). Furthermore, the NIRS could have analyzed the arterial, venous, or capillary blood, as well as their derived measurements representing the oxygen saturation in these three types of structures (Smith et al., 2009). Most of the cerebral blood volume is venous (Watzman et al., 2000), so the rSO~2~ might predominantly represent the saturation of hemoglobin in the venous blood bed. When the blood stream is blocked, the rSO~2~ could correspondingly descend. Additionally, rSO~2~ could represent a continuous measure of the balance between the delivery and utilization of cerebral oxygen (Buchner et al., 2000; Kolyva et al., 2013), such that the oxygen consumption increases after HBO treatment without raising the rSO~2~.

As for the decrease in PaO~2~ in the patients, a potential explanation is that HBO decreases lung function. There could be several mechanisms that might explain this phenomenon. The most reasonable and direct pathophysiologic explanation for our findings could be that extrapulmonary and neurogenic events were involved in the pathogenesis of acute pulmonary function, such as nitric oxide (NO) derived from neuronal nitric oxide synthase (nNOS) is involved in a neurogenic mechanism of HBO-induced lung injury that is linked to central nervous system oxygen toxicity through adrenergic/cholinergic pathways (Demchenko et al., 2007; Demchenko et al., 2008). HBO and TBI have been shown to increase the NO synthesis (Shaw et al., 2009). Therefore, NO could be a key to this phenomenon. A second explanation is that pulmonary function was reduced (Thorsen et al., 1998) in cases in which pulmonary O~2~ toxicity occurred with HBO treatment. However, no studies have provided evidence of any cerebral or pulmonary O~2~ toxicity with HBO treatment (Rockswold et al., 2010).

There were some limitations in this study. For safety and ethical reasons, we did not observe rSO~2~ dynamic changes in the hyperbaric chamber. Additionally, the sample size was small.

In conclusion, oxygen metabolism was abnormal in patients with a sub-acute TBI. HBO treatment did not immediately affect their cerebral oxygen metabolism. PaO~2~ was decreased with treatment, so it should be taken into consideration in TBI patients treated with HBO.
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